Cargando…

Adverse Drug Reactions among Children with Tuberculosis in Tashkent, Uzbekistan, 2019

The treatment of childhood tuberculosis can be challenging due to the lack of pediatric drug formulations and monitoring of drug-toxicity in routine settings. There are no published studies from Uzbekistan on the adverse drug reactions (ADR) associated with anti-tuberculosis treatment in children. I...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abdusalomova, Makhliyo, Denisiuk, Olga, Davtyan, Hayk, Gadoev, Jamshid, Abdusamatova, Barno, Parpieva, Nargiza, Sodikov, Abduvohid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308012/ https://www.ncbi.nlm.nih.gov/pubmed/34300026 http://dx.doi.org/10.3390/ijerph18147574

Ejemplares similares

Treatment Compliance of Multidrug Resistant Tuberculosis in Uzbekistan: Does Practice Follow Policy?
por: Usmanova, Ruzilya, et al.
Publicado: (2021)

Hospitalizations and Treatment Outcomes in Patients with Urogenital Tuberculosis in Tashkent, Uzbekistan, 2016–2018
por: Ismatov, Bakhtiyor, et al.
Publicado: (2021)

Operational Research to Inform Programmatic Approaches to the Management of Tuberculosis in Uzbekistan
por: Gadoev, Jamshid, et al.
Publicado: (2021)

Risk Factors for Unfavorable Treatment Outcomes among the Human Immunodeficiency Virus-Associated Tuberculosis Population in Tashkent City, Uzbekistan: 2013–2017
por: Massavirov, Sherali, et al.
Publicado: (2021)

Incidence Rate and Risk Factors for Tuberculosis among People Living with HIV: A 2015–2017 Cohort from Tashkent, Uzbekistan
por: Sadirova, Dilbar, et al.
Publicado: (2021)

Universal Access to Xpert MTB/RIF Testing for Diagnosis of Tuberculosis in Uzbekistan: How Well Are We Doing?
por: Turaev, Laziz, et al.
Publicado: (2021)

Characteristics and Treatment Outcomes of Patients with Tuberculosis Receiving Adjunctive Surgery in Uzbekistan
por: Riskiyev, Anvar, et al.
Publicado: (2021)

Treatment Outcomes of Isoniazid-Resistant (Rifampicin Susceptible) Tuberculosis Patients in Uzbekistan, 2017–2018
por: Sayfutdinov, Zayniddin, et al.
Publicado: (2021)

Scaling Up Molecular Diagnostic Tests for Drug-Resistant Tuberculosis in Uzbekistan from 2012–2019: Are We on the Right Track?
por: Yuldashev, Sharofiddin, et al.
Publicado: (2021)

Trends, Characteristics and Treatment Outcomes of Patients with Drug-Resistant Tuberculosis in Uzbekistan: 2013–2018
por: Safaev, Khasan, et al.
Publicado: (2021)

Diagnostic Procedures, Diagnoses, and Treatment Outcomes of Patients with Presumptive Tuberculosis Pleural Effusion in Uzbekistan
por: Abdugapparov, Fazlkhan, et al.
Publicado: (2021)

Recurrent tuberculosis and associated factors: A five - year countrywide study in Uzbekistan
por: Gadoev, Jamshid, et al.
Publicado: (2017)

AB042. The prevalence of sexual disorders in Tashkent (Uzbekistan)
por: Shavakhabov, Shavkat, et al.
Publicado: (2015)

Factors Associated with Unfavourable Treatment Outcomes in Patients with Tuberculosis: A 16-Year Cohort Study (2005–2020), Republic of Karakalpakstan, Uzbekistan
por: Gadoev, Jamshid, et al.
Publicado: (2021)

Default from tuberculosis treatment in Tashkent, Uzbekistan; Who are these defaulters and why do they default?
por: Hasker, Epco, et al.
Publicado: (2008)

Estimated costs for treatment and prophylaxis of newborn vitamin K deficiency bleeding in Tashkent, Uzbekistan
por: Tursunov, Doniyorjon, et al.
Publicado: (2018)

The Chemical Element Composition of Turmeric Grown in Soil–Climate Conditions of Tashkent Region, Uzbekistan
por: Jabborova, Dilfuza, et al.
Publicado: (2021)

Health Risk in Urbanizing Regions: Examining the Nexus of Infrastructure, Hygiene and Health in Tashkent Province, Uzbekistan
por: Veluswami Subramanian, Saravanan, et al.
Publicado: (2018)

Irrigated Crop Types Mapping in Tashkent Province of Uzbekistan with Remote Sensing-Based Classification Methods
por: Erdanaev, Elbek, et al.
Publicado: (2022)

Patient and health-care worker perspectives on the short-course regimen for treatment of drug-resistant tuberculosis in Karakalpakstan, Uzbekistan
por: Horter, Shona, et al.
Publicado: (2020)

Effectiveness and Safety of a Shorter Treatment Regimen in a Setting with a High Burden of Multidrug-Resistant Tuberculosis
por: Trubnikov, Aleksandr, et al.
Publicado: (2021)

Modelling the effect of short-course multidrug-resistant tuberculosis treatment in Karakalpakstan, Uzbekistan
por: Trauer, James M., et al.
Publicado: (2016)

Factors Associated with Unfavorable Treatment Outcomes in New and Previously Treated TB Patients in Uzbekistan: A Five Year Countrywide Study
por: Gadoev, Jamshid, et al.
Publicado: (2015)

Person-centred care in practice: perspectives from a short course regimen for multi-drug resistant tuberculosis in Karakalpakstan, Uzbekistan
por: Horter, Shona, et al.
Publicado: (2020)

Where there is hope: a qualitative study examining patients’ adherence to multi-drug resistant tuberculosis treatment in Karakalpakstan, Uzbekistan
por: Horter, Shona, et al.
Publicado: (2016)

Incidence rate and time to serious adverse events among rifampicin resistant tuberculosis patients in Georgia treated with new and repurposed anti-tuberculosis drugs, 2016–2018
por: Buziashvili, Mariana, et al.
Publicado: (2021)

Progress Toward Hepatitis B and Hepatitis C Elimination Using a Catalytic Funding Model — Tashkent, Uzbekistan, December 6, 2019–March 15, 2020
por: Dunn, Rick, et al.
Publicado: (2020)

Tashkent: Uzbek physics
Publicado: (1998)

Outcomes with a shorter multidrug-resistant tuberculosis regimen from Karakalpakstan, Uzbekistan
por: du Cros, Philipp, et al.
Publicado: (2021)

Optimising recruitment to a late-phase tuberculosis clinical trial: a qualitative study exploring patient and practitioner experiences in Uzbekistan
por: Wharton-Smith, Alexandra, et al.
Publicado: (2021)

Experience of emergency medical services provider training using online training of trainers during COVID-19: official development assistance project in Tashkent, Uzbekistan
por: Mun, Yongsuk, et al.
Publicado: (2022)

Effectiveness and safety of fully oral modified shorter treatment regimen for multidrug-resistant tuberculosis in Georgia, 2019–2020
por: Avaliani, Teona, et al.
Publicado: (2021)

Tashkent : la physique Ouzbek
Publicado: (1998)

Tashkent Conference on Nonlinearity with Disorder
por: Abdullaev, Fatkulla, et al.
Publicado: (1992)

Acquired bedaquiline resistance in Karakalpakstan, Uzbekistan
por: Nair, P., et al.
Publicado: (2022)

Assessing the Effectiveness of Type 2 Diabetes Screening in the Republic of Uzbekistan
por: Alieva, Anna, et al.
Publicado: (2022)

Primary bedaquiline resistance in Karakalpakstan, Uzbekistan
por: Moe, S., et al.
Publicado: (2023)

Applying Enhanced Real-Time Monitoring and Counting Method for Effective Traffic Management in Tashkent
por: Kutlimuratov, Alpamis, et al.
Publicado: (2023)

Mental health in Uzbekistan
por: Gazizova, Dina, et al.
Publicado: (2011)

EHMTI-0054. Monthly variation of Tashkent pediatric headache emergency department visits
por: Gazieva, S, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_m8cfpmmrpa2293f77gs1mr0l74